LUTONIX 035 DRUG COATED BALLOON PTA CATHETER 9010 LX3575860V

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2018-08-02 for LUTONIX 035 DRUG COATED BALLOON PTA CATHETER 9010 LX3575860V manufactured by C.r. Bard, Inc. (gfo).

Event Text Entries

[115783733] Analysis: the sample was not returned from the user facility; therefore, a device evaluation is unable to be performed. A lot history review nor a review of the device history record (dhr) could be completed due to the unknown lot number. Conclusion: the actual sample was discarded by the user facility. The hcp used the device off-label and inflated it over rbp. The hcp did not pre-dilate the lesion as suggested in the instructions for use (ifu). Although requested, additional event details, lot number and inflation pressure, were unavailable. Thus, a definitive root cause could not be determined based on the information received, but there is procedural evidence to suggest the vessel was not prepared properly and the lutonix dcb used off-label. It is unknown if patient issues contributed to the reported event. If additional information is received, a supplement report will be submitted with all relevant information. The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
Patient Sequence No: 1, Text Type: N, H10


[115783734] It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter was used off-label to treat a stenotic region in the patient's ureter. The hcp did not pre-dilate the ureteral stenosis before treating with the lutonix dcb. The balloon reportedly ruptured circumferentially during inflation. The rupture occurred after the balloon was inflated over rated burst pressure (rbp). The inflation pressure is specifically unknown at this time, but has been requested. The hcp used a boston scientific inflation device. The lutonix dcb was removed from the patient, but the hcp reported that a fragment of balloon material was left in the patient. The hcp used a snare to successfully retrieve the balloon fragment. The hcp exchanged the lutonix dcb for another balloon to complete the procedure. The sample was discarded by the user facility and will not be returned for evaluation. No adverse patient effects were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006513822-2018-00172
MDR Report Key7742039
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2018-08-02
Date of Report2018-08-02
Date of Event2018-07-06
Date Added to Maude2018-08-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJOHN RISSE
Manufacturer Street9409 SCIENCE CENTER DR
Manufacturer CityNEW HOPE MN 55428
Manufacturer CountryUS
Manufacturer Postal55428
Manufacturer Phone7634632917
Manufacturer G1C.R. BARD, INC. (GFO)
Manufacturer Street289 BAY ROAD
Manufacturer CityQUEENSBURY NY 12804
Manufacturer CountryUS
Manufacturer Postal Code12804
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Generic NameDRUG COATED PTA BALLOON
Product CodePRC
Date Received2018-08-02
Model Number9010
Catalog NumberLX3575860V
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerC.R. BARD, INC. (GFO)
Manufacturer Address289 BAY ROAD QUEENSBURY NY 12804 US 12804


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-08-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.